Article List

WPRIM Management System> DCMS> International Neurourology Journal> 2017> 21> 3

Volume: 21 Issue: 3

1. The Authors Reply: Reply on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”.	Page:231—232
2. Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”.	Page:229—230
3. Clinical Significance of Periurethral Calcification According to the Location in Men With Lower Urinary Tract Symptoms and a Small Prostate Volume.	Page:220—228
4. Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder.	Page:212—219
5. Is There Any Difference Between Depression and Anxiety in Overactive Bladder According to Sex? A Systematic Review and Meta-Analysis.	Page:204—211
6. Seasonal Changes in Lower Urinary Tract Symptoms in Japanese Men With Benign Prostatic Hyperplasia Treated With α₁-Blockers.	Page:197—203
7. Clean Intermittent Self-Catheterization as a Treatment Modality for Urinary Retention: Perceptions of Urologists.	Page:189—196
8. Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spinal Cord Injury.	Page:178—188
9. Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate.	Page:171—177
10. Comparison of 5 Different Rat Models to Establish a Standard Animal Model for Research Into Interstitial Cystitis.	Page:163—170
11. Particulate Matter (Fine Particle) and Urologic Diseases.	Page:155—162
12. Fine Particulate Matter and Urology: Emphasis on the Lower Urinary Tract.	Page:153—154